Quidel Corp. has agreed to take on Alere Inc.'s Triage portfolio, including Triage Meterpro's toxicology and cardiovascular, and B-type Naturietic Peptide (BNP) assay group for $400 million. The divestment will pave the way for Waltham, Mass.-based Alere to meet antitrust hurdles in its acquisition by Abbott Park, Ill.-based Abbott Laboratories. Read More
